Stocks poised to move as this corner of the cancer therapy market heats up
Radiopharmaceuticals seek to destroy cancer cells by binding a radioactive particle to a targeted molecule and then dispatching it directly into the tumor.
Source: cnbc.com
Gregory Renza News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Gregory Renza. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Gregory Renza Today - Breaking & Trending Today
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A
Targeted radiopharmaceuticals, which deliver radiation directly into tumors, has caught the eye of big pharma.
Source: nbcnewyork.com
Exelixis (EXEL) Q1 2024 Earnings Call Transcript
EXEL earnings call for the period ending March 31, 2024.
Source: fool.com
IDEAYA Biosciences to Participate in Upcoming May 2024 Investor Relations Event
/PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted...
Source: prnewswire.com
Vertex acquires Alpine Immune Sciences for $4.9, adds renal disease drug
Currently, the Alpine drug is set to enter a Phase 3 clinical trial by the end of the year and studies of its application in renal indications and autoimmune cytopenias are ongoing.
Source: mmm-online.com